Freedom Caucus Urges House GOP to ‘Force’ Border Security Measures in Govt Spending Bill

Lawmakers highlight their concerns over illegal immigration and drug trafficking through southern border. A group of House Republicans urged their colleagues on Monday to reject a government spending deal that doesn’t address the “open border” and “radical progressive” policies led by Democrats and President Joe Biden. As Congress labors toward a spending deal for the

Biden Signs Executive Order Aimed at Advancing Study of Women’s Health

President Joe Biden signed an executive order on Monday that is aimed at facilitating improved studies on women’s health. The order is based partly on improved data collection and is aimed at providing enhanced opportunities for biomedical research through easier access to funding. Studies and medical research were previously conducted mostly on men, but a

Judge Opens Possibility of Jury Examining Records in Trump Document Case

The two sets of competing jury instructions to be drafted will now allow for both prosecutor and defense scenarios. The judge in former president Donald Trump’s classified documents case has ordered the preparation of jury instructions in a way that demands the parties to both consider competing sets of facts, on the premise that President

Judge’s Jury Instructions Hold Door Wide Open to Trump Win in Classified Documents Case

The two sets of competing jury instructions to be drafted will now allow for both prosecutor and defense scenarios. The judge in former president Donald Trump’s classified documents case has ordered the preparation of jury instructions in a way that holds the door wide open to a potential dismissal of the case, on the premise

AstraZeneca Capping Inhaler Costs for Eligible Customers at $35 From June 1

The new cap will apply to AstraZeneca’s entire range of inhaler products including Symbicort, Breztri Aerosphere, and Airsupra inhalers. United Kingdom-based pharmaceutical giant AstraZeneca has announced it will cap out-of-pocket costs for its inhalers across the United States at $35 for eligible patients. The big pharma company announced on March 18 that the cap will